Tamarly Intelligence
Form 13F · Ascendis Pharma A/S

Who Holds Ascendis Pharma A/S (ASND)? 301 Institutional Holders, Q2 2026

Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 301 holders, $15.3 billion in total.

Largest holders

The 100 largest by value. Change in shares against Q1 2026.

ManagerSharesValueChange
RA CAPITAL MANAGEMENT, L.P.10,281,496$2.7 billionNew13F
Avoro Capital Advisors LLC5,111,111$1.4 billionNew13F
WESTFIELD CAPITAL MANAGEMENT CO LP4,798,267$1.3 billionNew13F
Jupiter Topco LLC3,648,772$973 millionNew13F
FMR LLC3,545,575$946 millionNew13F
Artisan Partners Limited Partnership2,634,024$703 millionNew13F
BlackRock, Inc.2,211,833$590 millionNew13F
Capital International Investors1,988,614$530 millionNew13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1,875,301$500 millionNew13F
FRANKLIN RESOURCES INC1,862,503$497 millionNew13F
WELLINGTON MANAGEMENT GROUP LLP1,548,636$413 millionNew13F
AMERICAN CENTURY COMPANIES INC1,400,575$374 millionNew13F
PERCEPTIVE ADVISORS LLC1,163,721$310 millionNew13F
Capital World Investors906,081$242 millionNew13F
PRINCIPAL FINANCIAL GROUP INC873,502$233 millionNew13F
Polar Capital Holdings Plc616,908$165 millionNew13F
GOLDMAN SACHS GROUP INC559,534$149 millionNew13F
MORGAN STANLEY544,393$145 millionNew13F
Invesco Ltd.414,196$110 millionNew13F
GEODE CAPITAL MANAGEMENT, LLC403,151$108 millionNew13F
UBS Group AG401,881$107 millionNew13F
ALLIANCEBERNSTEIN L.P.399,292$106 millionNew13F
Vestal Point Capital, LP375,000$100 millionNew13F
JPMORGAN CHASE & CO367,781$97 millionNew13F
FIL Ltd345,567$92 millionNew13F
AMERIPRISE FINANCIAL INC320,514$85 millionNew13F
Bank of New York Mellon Corp319,412$85 millionNew13F
TWO SIGMA INVESTMENTS, LP305,803$82 millionNew13F
MILLENNIUM MANAGEMENT LLC266,708$71 millionNew13F
BANK OF AMERICA CORP /DE/260,638$70 millionNew13F
Tri Locum Partners LP258,740$69 millionNew13F
ORBIMED ADVISORS LLC244,456$65 millionNew13F
SEI INVESTMENTS CO237,869$63 millionNew13F
Pictet Asset Management Holding SA234,039$62 millionNew13F
PFM Health Sciences, LP233,171$62 millionNew13F
Spyglass Capital Management LLC215,398$57 millionNew13F
ARS Investment Partners, LLC210,462$56 millionNew13F
SILVERARC CAPITAL MANAGEMENT, LLC206,234$55 millionNew13F
NEW YORK STATE COMMON RETIREMENT FUND191,791$51 millionNew13F
Empowered Funds, LLC187,271$50 millionNew13F
JANE STREET GROUP, LLC187,141$50 millionNew13F
Allspring Global Investments Holdings, LLC178,738$48 millionNew13F
BNP PARIBAS FINANCIAL MARKETS173,449$46 millionNew13F
FRED ALGER MANAGEMENT, LLC171,447$46 millionNew13F
Rock Springs Capital Management LP168,750$45 millionNew13F
RICE HALL JAMES & ASSOCIATES, LLC148,644$40 millionNew13F
USS Investment Management Ltd141,010$38 millionNew13F
CITADEL ADVISORS LLC137,889$37 millionNew13F
BRAUN STACEY ASSOCIATES INC132,682$35 millionNew13F
Walleye Capital LLC126,005$34 millionNew13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP125,772$34 millionNew13F
RENAISSANCE TECHNOLOGIES LLC119,699$32 millionNew13F
TD Asset Management Inc119,085$32 millionNew13F
Resolute Capital Asset Partners LLC118,627$32 millionNew13F
Eagle Health Investments LP106,158$28 millionNew13F
First Turn Management, LLC104,877$28 millionNew13F
NORTHERN TRUST CORP103,933$28 millionNew13F
VANGUARD PORTFOLIO MANAGEMENT LLC103,540$28 millionNew13F
Fiera Capital Corp103,313$28 millionNew13F
Woodline Partners LP102,469$27 millionNew13F
Defilade Capital Management, L.P.94,843$25 millionNew13F
SAPIENT CAPITAL LLC92,162$25 millionNew13F
Synergy Asset Management, LLC91,228$24 millionNew13F
Nuveen, LLC90,318$24 millionNew13F
CANADA PENSION PLAN INVESTMENT BOARD85,478$23 millionNew13F
LOOMIS SAYLES & CO L P78,941$21 millionNew13F
BARCLAYS PLC76,540$20 millionNew13F
Driehaus Capital Management LLC70,061$19 million-45%13F
ADAGE CAPITAL PARTNERS GP, L.L.C.66,500$18 millionNew13F
CASTLEARK MANAGEMENT LLC61,696$16 millionNew13F
Atika Capital Management LLC61,000$16 millionNew13F
VOYA INVESTMENT MANAGEMENT LLC54,332$14 millionNew13F
WELLS FARGO & COMPANY/MN50,353$13 millionNew13F
Cormorant Asset Management, LP50,000$13 millionNew13F
RHUMBLINE ADVISERS48,612$13 millionNew13F
DAFNA Capital Management LLC48,469$13 millionNew13F
Russell Investments Group, Ltd.48,360$13 millionNew13F
Trexquant Investment LP47,269$13 millionNew13F
ENVESTNET ASSET MANAGEMENT INC45,776$12 millionNew13F
Integral Health Asset Management, LLC45,000$12 millionNew13F
NOMURA ASSET MANAGEMENT CO LTD43,678$12 millionNew13F
XTX Topco Ltd43,289$12 millionNew13F
Eversept Partners, LP41,621$11 millionNew13F
Nicholas Investment Partners, LP38,160$10 millionNew13F
Aberdeen Group plc36,512$10 millionNew13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM33,383$9 millionNew13F
Longaeva Partners L.P.32,036$9 millionNew13F
Catalio Capital Management, LP31,759$8 millionNew13F
Balyasny Asset Management L.P.31,023$8 millionNew13F
D. E. Shaw & Co., Inc.30,883$8 millionNew13F
Affinity Asset Advisors, LLC30,000$8 millionNew13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC29,303$8 millionNew13F
CITIGROUP INC28,693$8 millionNew13F
ADAR1 Capital Management, LLC28,604$8 millionNew13F
Matisse Capital28,107$7 millionNew13F
VICTORY CAPITAL MANAGEMENT INC27,540$7 millionNew13F
ROYAL BANK OF CANADA27,283$7 millionNew13F
CAPITAL INTERNATIONAL SARL26,222$7 millionNew13F
DIVERSIFIED TRUST CO25,991$7 millionNew13F
Caption Management, LLC25,500$7 millionNew13F

Questions and answers

How many institutions hold Ascendis Pharma A/S?
301 managers reported Ascendis Pharma A/S on Form 13F for the quarter ended 30 June 2026, against 8 the quarter before.
Who is the largest institutional holder of Ascendis Pharma A/S?
RA CAPITAL MANAGEMENT, L.P., with 10,281,496 shares worth $2.7 billion on its 13F for Q2 2026.
How many institutions bought or sold out of Ascendis Pharma A/S in Q2 2026?
294 managers reported a new position and 1 reported none after holding it the quarter before.
See every holder, the full history and an alert when the next 13F filings land; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Ascendis Pharma A/S, Q2 2026", https://app.tamarly.ai/holders/ascendis-pharma-a-s, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Who Holds Ascendis Pharma A/S (ASND)? 301 Institutional Holders, Q2 2026 | Tamarly